Viewing Study NCT01605708


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2025-12-29 @ 8:38 AM
Study NCT ID: NCT01605708
Status: TERMINATED
Last Update Posted: 2013-10-28
First Post: 2011-10-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Sponsor: Regeneron Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-06
Start Date Type: None
Primary Completion Date: 2013-04
Primary Completion Date Type: ACTUAL
Completion Date: 2013-04
Completion Date Type: ACTUAL
First Submit Date: 2011-10-12
First Submit QC Date: None
Study First Post Date: 2012-05-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2013-10-28
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2013-09-27
Last Update Post Date: 2013-10-28
Last Update Post Date Type: ESTIMATED